Illumina: Joydeep Goswami
Illumina has permanently installed Joydeep Goswami as CFO, effective immediately. He had been serving in the role on an interim basis since July.
Goswami will be responsible for Illumina's financial planning and analysis, accounting, investor relations, internal audit, tax, and treasury functions. He will also continue to lead the corporate development and strategic planning function, as he has done since 2019.
Prior to joining Illumina, he was president of clinical next-generation sequencing and oncology at Thermo Fisher Scientific. He also held executive roles at Life Technologies. He began his career at management consulting firm McKinsey & Company. Goswami holds a doctorate in chemical engineering and MBA from MIT.